Please assess the completion status of the following clinical trial:

Trial Title: Intrapleural Cryotherapy for Malignant Pleural Mesothelioma

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~* Subject provides informed consent~* Subject is \>18 years of age~* Subject is deemed competent for making medical decisions~* Subject is scheduled to undergo pleuroscopy as part of their standard care for pre-operative clinical staging of malignant pleural mesothelioma~* A negative pregnancy test is required in women of child-bearing potential, as standard of care.~* Subject is mentally capable of understanding study procedures.~Exclusion Criteria~Study subject has any disease or condition that interferes with safe completion of the study including:~* Platelet count \< 50K, coagulopathy defined as an International Normalized Ratio (INR) \> 1.5~* Anticoagulants such as clopidogrel, heparin, low-molecular weight heparin, warfarin or other novel anticoagulants have not been held for the standard time period published~* Hemodynamic instability with systolic blood pressure \<90 mmHg or heart rate \> 120 beats/min, unless deemed to be stable with these values by the surgical or interventional pulmonary attending physicians.~* Hypoxemia with pulse oximetry values \<88% or partial pressure of oxygen in arterial blood (PaO2) \< 60 on baseline oxygen requirements.~* Concurrent participation in another study involving investigational drugs or investigational medical devices~* Absence of or limited access to the pleural space during medical pleuroscopy.~* Inability to read and understand the necessary study documents.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cryotherapy (Type: EXPERIMENTAL): Cryospray and biopsies
- Control (Type: OTHER): Biopsies

Based on this trial design, predict the completion outcome and termination type (if applicable).